Yavuz Yildirim

DDS | Oral and Maxillofacial Surgeon



  
  11655 Solzman Rd, Cincinnati
  Ohio, 45249-1232

  513-791-0550    Maps & Directions
Yavuz Yildirim is a Cincinnati, Ohio based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 11655 Solzman Rd, Cincinnati. Patients can reach him at 513-791-0550.
Yavuz Yildirim deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Yavuz Yildirim speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Yavuz Yildirim
Specialization: Oral and Maxillofacial Surgeon
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:11655 Solzman Rd, Cincinnati,
Ohio, 45249-1232
Phone:513-791-0550
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6305009473
Enrollment ID: I20170929002529
NPI Number: 1255627311
NPI Enumeration Date: 27 Jun, 2011
NPI Last Update On: 02 Feb, 2024

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 11655 Solzman Rd,
Cincinnati, Ohio
Zip: 45249-1232
Phone Number: 513-791-0550
Patients can reach Yavuz Yildirim at 11655 Solzman Rd, Cincinnati, Ohio or can call to book an appointment on 513-791-0550. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.

Comments/ Reviews: